Generate Biomedicines, Inc. (GENB) vs Nuvation Bio Inc. (NUVB)

Generate Biomedicines, Inc. and Nuvation Bio Inc. are both Biotechnology companies. Generate Biomedicines, Inc. and Nuvation Bio Inc. are of similar size ($1.4B and $1.3B). Nuvation Bio Inc. has the higher net margin (−67.4% vs −1,381.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Nuvation Bio Inc. leads on 10 and Generate Biomedicines, Inc. on 5.

Valuation

Metric GENB NUVB Biotechnology median
P/E n/m n/m 10.01
P/S 59.96 6.84 9.02
P/B 3.31 6.05 2.13
Price to free cash flow n/m n/m 24.99
EV/EBITDA n/m n/m 0.64
EV/Sales 41.05 4.96 9.01
Earnings yield (42.17%) (10.04%) (34.01%)
Free cash flow yield (20.00%) (7.84%) (24.62%)

Profitability

Metric GENB NUVB Biotechnology median
Gross margin 100.00% 85.79% 70.18%
Operating margin (1,382.04%) (61.17%) 0.00%
Net margin (1,381.76%) (67.38%) 0.00%
Free cash flow margin (1,199.36%) (53.62%) 0.00%
Return on equity 1,091.11% (49.09%) (50.72%)
Return on assets (56.30%) (19.70%) (45.56%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GENB NUVB Biotechnology median
Revenue growth (TTM) — 654.19% 7.42%
EPS growth (last fiscal year) (13.66%) 71.56% 29.36%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GENB NUVB Biotechnology median
Debt to equity 0.02 1.25 0.00
Current ratio 5.01 7.45 4.72
Net debt to EBITDA 0.97 2.26 1.01

Dividend

Metric GENB NUVB Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric GENB NUVB Biotechnology median
Market cap 1.27b 1.38b 157.22m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack